Breastcancer

Oncology
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

BriaCell Therapeutics
BriaCell TherapeuticsWEST VANCOUVER, British Columbia, Canada
1 program
1
SV-BR-1-GMPhase 1/21 trial
Active Trials
NCT03066947CompletedEst. Nov 2018
PharmaEssentia
PharmaEssentiaMA - Burlington
2 programs
2
OraxolPhase 11 trial
OraxolPhase 11 trial
Active Trials
NCT04168957TerminatedEst. Nov 2020
NCT03165955CompletedEst. Nov 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BriaCell TherapeuticsSV-BR-1-GM
PharmaEssentiaOraxol
PharmaEssentiaOraxol

Clinical Trials (3)

SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer

Start: May 2017Est. completion: Nov 2018
Phase 1/2Completed

An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007

Start: Oct 2017Est. completion: Nov 2020
Phase 1Terminated

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Start: May 2017Est. completion: Nov 2018
Phase 1Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space